This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MKC's Flavorful Growth Journey: Strategic Efforts Fuel Momentum
by Zacks Equity Research
McCormick has positioned itself well to navigate challenging macroeconomic conditions and continue its recovery in volume growth across key regions.
Molson Coors Rises 5% Post Q3 Earnings: Buy, Hold or Avoid the Stock?
by Zacks Equity Research
TAP makes significant progress with the Acceleration Plan. The company's revitalization plan and the premiumization of the global portfolio also bode well.
FLO Q3 Earnings Top, View Narrowed on Volatile Consumer Trends
by Zacks Equity Research
Flowers Foods' Q3 results shows significant margin improvements and strong bottom-line growth, despite top-line pressures largely driven by external factors.
Vital Farms Q3 Earnings Beat Estimates on Higher Sales & Gross Margin
by Zacks Equity Research
VITL Q3 results reflect robust sales momentum driven by higher volumes and favorable pricing, supported by its focus on ethical food production.
Here's Why WK Kellogg Stock is Down 8% Despite Q3 Earnings Beat
by Zacks Equity Research
KLG's Q3 earnings and net sales exceed expectations but decline year over year. However, the company raises its 2024 adjusted EBITDA growth forecast.
Is Brown-Forman Stock a Buy, Sell or Hold at a P/E Multiple of 22.4x?
by Zacks Equity Research
BF.B's premiumization strategy and global expansion efforts position it for long-term growth, though near-term headwinds remain a concern.
Hain Celestial Q1 Loss Wider Than Estimates, Organic Sales Slip Y/Y
by Zacks Equity Research
HAIN's Q1 sales fall 7.2% year over year. It aims for growth in fiscal 2025 through operational efficiencies and improved margins.
HSY Down on Q3 Earnings Miss, View Cut Amid Weak Consumer Trends
by Zacks Equity Research
The Hershey Company's Q3 results reflect lower net sales and earnings amid a challenging consumer environment and high cocoa prices.
Clorox Stock Gains 3.8% in a Week on Solid Q1 Results: Buy or Avoid?
by Zacks Equity Research
CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
B&G Foods Cuts View on Q3 Earnings Miss, Soft Consumption Trends
by Zacks Equity Research
BGS Q3 results are impacted by lower unit volumes and the Green Giant U.S. shelf-stable divestiture, partly offset by better net pricing and product mix.
Archer Daniels Reports Preliminary Q3 Results, Trims 2024 EPS Outlook
by Zacks Equity Research
ADM announces preliminary results for the third quarter of 2024. The Nutrition business witnesses lower-than- expected results due to the weaker market conditions.
FEMSA Sells Refrigeration and Foodservice Division to Mill Point
by Zacks Equity Research
FMX sells its refrigeration and food service operations to Mill Point Capital, aiming to enhance long-term value by focusing on core business areas.
Freshpet's Q3 Earnings Top Estimates, Sales Rise 26% Y/Y
by Zacks Equity Research
FRPT reaches a key milestone, marking its 25th consecutive quarter of more than 25% year-on-year net sales growth.
Freshpet, Inc. (FRPT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Freshpet (FRPT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
MED Q3 Earnings Beat, Revenues Fall on Customer Acquisition Challenges
by Zacks Equity Research
Medifast's Q3 results lower earnings and revenues, highlighting challenges in customer acquisition. Management issues soft guidance for the fourth quarter.
Diageo Stock Declines 8% in a Month: What Should Investors Do Next?
by Zacks Equity Research
DEO has been committed to strengthening its portfolio of brands and countering challenges like a cautious consumer market and retailer inventory adjustments.
Pre-Markets Holding Breath Ahead of Biggest Week of 2024
by Mark Vickery
Between the General Election Tuesday and a new Fed interest rate Thursday, pre-markets are understandably mute.
Are Consumer Staples Stocks Lagging Freshpet (FRPT) This Year?
by Zacks Equity Research
Here is how Freshpet (FRPT) and Philip Morris (PM) have performed compared to their sector so far this year.
Freshpet (FRPT) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Freshpet (FRPT) delivered earnings and revenue surprises of 71.43% and 2.34%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Can Molson Coors Maintain Its Earnings Surprise Trend in Q3?
by Zacks Equity Research
TAP's Q3 results are expected to reflect gains from a strong brand portfolio, success across its geographic segments and focus on revitalization plan.
AB InBev Q3 Earnings Beat Estimates, Organic Revenues Rise 2.1%
by Zacks Equity Research
BUD posts solid earnings results in third-quarter 2024. Organic revenues rise 2.1%, led by the ongoing premiumization and higher revenue per hectoliter.
Monster Beverage Gears Up for Q3 Earnings: Here's What You Should Know
by Zacks Equity Research
MNST's third-quarter 2024 results are likely to reflect gains from strength in its energy drinks category and product launches.
Medifast Gears Up for Q3 Earnings: Here's What You Should Know
by Zacks Equity Research
MED's Q3 results may reflect customer acquisition challenges and a decline in active earning OPTAVIA Coaches due to the increasing adoption of GLP-1 medications.
Kellanova Q3 Earnings Top Estimates, Organic Sales Increase Y/Y
by Zacks Equity Research
Kellanova's Q3 results reflect the success of its growth-focused and profitable portfolio strategy. The improved price/mix and volumes boost organic sales.